Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
Macdonald ER, Amorim NML, Hagstrom AD, Markovic K, Simar D, Ward RE, et al. Evaluating the effect of upper-body morbidity on quality of life following primary breast cancer treatment: a systematic review and meta-analysis. J Cancer Surviv. 2023. https://doi.org/10.1007/s11764-023-01395-0.
Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, et al. Muscle strength in breast cancer patients receiving different treatment regimes. J Cachexia Sarcopenia Muscle. 2017;8:305–16. https://doi.org/10.1002/jcsm.12165.
Jørgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sørensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021;7:70. https://doi.org/10.1038/s41523-021-00276-y.
Article PubMed PubMed Central Google Scholar
Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer. 2018;25:309–14. https://doi.org/10.1007/s12282-018-0830-3.
Fortin J, Leblanc M, Elgbeili G, Cordova MJ, Marin MF, Brunet A. The mental health impacts of receiving a breast cancer diagnosis: a meta-analysis. Br J Cancer. 2021;125:1582–92. https://doi.org/10.1038/s41416-021-01542-3.
Article PubMed PubMed Central Google Scholar
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300–22.
Gormley M, Knobf MT, Vorderstrasse A, Aouizerat B, Hammer M, Fletcher J, et al. Exploring the effects of genomic testing on fear of cancer recurrence among breast cancer survivors. Psychooncology. 2021;30:1322–31. https://doi.org/10.1002/pon.5679.
Oliveira MEC, Torres GSV, Franklin RG, Gomes KAL, Nóbrega WFS, Fernandes TP, et al. Cognitive impairments associated with chemotherapy in women with breast cancer: a meta-analysis and meta-regression. Braz J Med Biol Res. 2023;56: e12947. https://doi.org/10.1590/1414-431X2023e12947.
Article CAS PubMed PubMed Central Google Scholar
Neilson T, Huynh V, Macdonald A, Romandetti K, Ahrendt G, Hampanda K, et al. Financial toxicity of breast cancer care: the patient perspective through surveys and interviews. J Surg Res. 2023;281:122–9. https://doi.org/10.1016/j.jss.2022.08.021.
Hamood R, Hamood H, Merhasin I, Keinan-Boker L. Work transitions in breast cancer survivors and effects on quality of life. J Occup Rehabil. 2019;29:336–49. https://doi.org/10.1007/s10926-018-9789-3.
Hughes S, Jaremka LM, Alfano CM, Glaser R, Povoski SP, Lipari AM, et al. Social support predicts inflammation, pain, and depressive symptoms: longitudinal relationships among breast cancer survivors. Psychoneuroendocrinology. 2014;42:38–44. https://doi.org/10.1016/j.psyneuen.2013.12.016.
Article PubMed PubMed Central Google Scholar
Campos E, Silva AC, Bergmann A, Araujo CM, Montenegro AKS, Tenorio ADS, Dantas D. Association of handgrip strength with quality of life in breast cancer survivors: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2022;23:3237–45. https://doi.org/10.31557/APJCP.2022.23.10.3237.
Hutter N, Vogel B, Alexander T, Baumeister H, Helmes A, Bengel J. Are depression and anxiety determinants or indicators of quality of life in breast cancer patients? Psychol Health Med. 2013;18:412–9. https://doi.org/10.1080/13548506.2012.736624.
Morishita S, Kasahara R, Yamamoto Y, Jinbo R, Takano A, Yasuda M, et al. Differences in the relationships between muscle strength, muscle mass, balance function, and quality of life for middle-aged and older breast cancer survivors. Integr Cancer Ther. 2022;21:15347354221138574. https://doi.org/10.1177/15347354221138574.
Article PubMed PubMed Central Google Scholar
Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr. 2016;14:22. https://doi.org/10.1186/s12963-016-0091-3.
Article PubMed PubMed Central Google Scholar
Oliver A, Greenberg CC. Measuring outcomes in oncology treatment: the importance of patient-centered outcomes. Surg Clin North Am. 2009;89:17–vii. https://doi.org/10.1016/j.suc.2008.09.015.
Article PubMed PubMed Central Google Scholar
van Leeuwen M, Husson O, Alberti P, Arraras JI, Chinot OL, Costantini A, et al. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes. 2018;16:114. https://doi.org/10.1186/s12955-018-0920-0.
Article PubMed PubMed Central Google Scholar
Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009;10:865–71. https://doi.org/10.1016/S1470-2045(09)70200-1.
Ediebah DE, Quinten C, Coens C, Ringash J, Dancey J, Zikos E, et al. Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer. 2018;124:3409–16. https://doi.org/10.1002/cncr.31556.
van Nieuwenhuizen AJ, Buffart LM, Brug J, Leemans CR, Verdonck-de Leeuw IM. The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol. 2015;51:1–11. https://doi.org/10.1016/j.oraloncology.2014.09.002.
Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, et al. Quality of life after breast cancer diagnosis and survival. J Clin Oncol. 2011;29:406–12. https://doi.org/10.1200/JCO.2010.30.6951.
Staren ED, Gupta D, Braun DP. The prognostic role of quality of life assessment in breast cancer. Breast J. 2011;17:571–8. https://doi.org/10.1111/j.1524-4741.2011.01151.x.
Gupta D, Granick J, Grutsch JF, Lis CG. The prognostic association of health-related quality of life scores with survival in breast cancer. Support Care Cancer. 2007;15:387–93. https://doi.org/10.1007/s00520-006-0165-z.
Takada K, Kashiwagi S, Fukui Y, Goto W, Asano Y, Morisaki T, et al. Prognostic value of quality-of-life scores in patients with breast cancer undergoing preoperative chemotherapy. BJS Open. 2019;3:38–47. https://doi.org/10.1002/bjs5.50108.
Article CAS PubMed Google Scholar
De Aguiar SS, Bergmann A, Mattos IE. Quality of life as a predictor of overall survival after breast cancer treatment. Qual Life Res. 2014;23:627–37. https://doi.org/10.1007/s11136-013-0476-8.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https://doi.org/10.1136/bmj.n71.
Article PubMed PubMed Central Google Scholar
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2019. Available from https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Efficace F, Therasse P, Piccart MJ, Coens C, van Steen K, Welnicka-Jaskiewicz M, et al. Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol. 2004;22:3381–8. https://doi.org/10.1200/JCO.2004.02.060.
DiSipio T, Hayes S, Battistutta D, Newman B, Janda M. Patterns, correlates, and prognostic significance of quality of life following breast cancer. Psychooncology. 2011;20:1084–91.
Comments (0)